Medications for Familial Mediterranean Fever

9 results
  • Camber Pharmaceuticals, Inc.
    Usage: Colchicine tablets are indicated for the prophylaxis and treatment of acute gout flares and for the treatment of familial Mediterranean fever (FMF) in adults and children aged four years and older.
  • Zydus Pharmaceuticals USA Inc.
    Usage: Colchicine tablets are indicated for the prophylaxis and treatment of acute gout flares, as well as for the treatment of familial Mediterranean fever (FMF) in adults and children aged four years or older.
  • DIRECT RX
    Usage: Colchicine Tablets, USP are indicated for the prophylaxis and treatment of acute gout flares. Additionally, they are used in adults and children aged four or older for the treatment of familial Mediterranean fever (FMF).
  • Ascend Laboratories, LLC
    Usage: Colchicine tablets are indicated for the treatment of familial Mediterranean fever (FMF) in adults and children aged four years and older.
  • Actavis Pharma, Inc.
    Usage: Colchicine tablets are indicated for the prophylaxis and treatment of acute gout flares and for the treatment of familial Mediterranean fever (FMF) in adults and children aged four years and older.
  • NorthStar RxLLC
    Usage: Colchicine tablets are indicated for the prophylaxis and treatment of acute gout flares, as well as for the treatment of familial Mediterranean fever (FMF) in adults and children aged four years and older.
  • Amneal Pharmaceuticals LLC
    Usage: Colchicine tablets are indicated for the prophylaxis and treatment of acute gout flares, especially at the first sign of a flare. They are also used in adults and children aged four or older for the treatment of familial Mediterranean fever (FMF).
  • AR Scientific Inc.
    Usage: COLCRYS (colchicine) is indicated for the prophylaxis and treatment of acute gout flares, and for treating familial Mediterranean fever (FMF) in adults and children aged 4 years or older.
  • Ilaris

    (canakinumab)
    Novartis Pharmaceuticals Corporation
    Usage: ILARIS (canakinumab) is indicated for treating autoinflammatory Periodic Fever Syndromes, including CAPS, TRAPS, HIDS/MKD, and FMF; active Still's Disease in patients 2 years and older; and symptomatic treatment of gout flares in adults when other treatments are unsuitable.